Mild cognitive impairment as a diagnostic entity
- R. Petersen
- Psychology, MedicineJournal of Internal Medicine
- 1 September 2004
It is suggested that the diagnosis of mild cognitive impairment can be made in a fashion similar to the clinical diagnoses of dementia and AD, and an algorithm is presented to assist the clinician in identifying subjects and subclassifying them into the various types of MCI.
Mild cognitive impairment: clinical characterization and outcome.
- R. Petersen, G. Smith, S. Waring, R. Ivnik, E. Tangalos, E. Kokmen
- Psychology, MedicineArchives of Neurology
- 1 March 1999
Patients who meet the criteria for MCI can be differentiated from healthy control subjects and those with very mild AD, and appear to constitute a clinical entity that can be characterized for treatment interventions.
The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's…
- M. Albert, S. DeKosky, C. Phelps
- Psychology, MedicineAlzheimer's & Dementia
- 1 May 2011
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
- M. Dejesus‐Hernandez, I. Mackenzie, R. Rademakers
- BiologyNeuron
- 20 October 2011
Current concepts in mild cognitive impairment.
- R. Petersen, R. Doody, B. Winblad
- Psychology, MedicineArchives of Neurology
- 1 December 2001
A group of experts on aging and MCI from around the world in the fields of neurology, psychiatry, geriatrics, neuropsychology, neuroimaging, neuropathology, clinical trials, and ethics was convened to summarize the current state of the field of MCI.
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
- B. Winblad, K. Palmer, R. Petersen
- Psychology, MedicineJournal of Internal Medicine
- 1 September 2004
A multidisciplinary, international group of experts discussed the current status and future directions of MCI, with regard to clinical presentation, cognitive and functional assessment, and the role of neuroimaging, biomarkers and genetics.
The Alzheimer's disease neuroimaging initiative.
- S. Mueller, M. Weiner, L. Beckett
- Psychology, BiologyNeuroimaging clinics of North America
- 1 November 2005
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- C. Jack, D. Knopman, J. Trojanowski
- Biology, PsychologyLancet Neurology
- 31 January 2010
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
- I. Litvan, J. Goldman, M. Emre
- Psychology, MedicineMovement Disorders
- 1 March 2012
These diagnostic criteria will support future research efforts to identify at the earliest stage those PD patients at increased risk of progressive cognitive decline and dementia who may benefit from clinical interventions at a predementia stage.
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
- M. Hutton, C. Lendon, P. Heutink
- BiologyNature
- 18 June 1998
Thirteen families have been described with an autosomal dominantly inherited dementia named frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), historically termed Pick's…
...
...